Javier Olascoaga

Defining secondary progressive multiple sclerosis

Johannes Lorscheider, Katherine Buzzard, Vilija Jokubaitis et al. · Brain · 2016 · 416 citations · Full text

Life Sciences, Neurology, Neuroscience +12

Antibodies to MOG and AQP4 in adults with neuromyelitis optica and suspected limited forms of the disease

Romana Höftberger, María Sepúlveda, Thaís Armangué et al. · Multiple Sclerosis Journal · 2014 · 280 citations

Medicine, Immunology, Neurology +16

Predictors of long‐term disability accrual in relapse‐onset multiple sclerosis

Vilija Jokubaitis, Tim Spelman, Tomáš Kalinčík et al. · Annals of Neurology · 2016 · 194 citations · Full text

Medicine, Neurology, Disability Management +15

Treatment effectiveness of alemtuzumab compared with natalizumab, fingolimod, and interferon beta in relapsing-remitting multiple sclerosis: a cohort study

Tomáš Kalinčík, J William L Brown, Neil P. Robertson et al. · The Lancet Neurology · 2017 · 162 citations · Full text

Life Sciences, Neurology, Pharmacotherapy +16

Neuromyelitis optica spectrum disorders

María Sepúlveda, Thaís Armangué, Núria Solà‐Valls et al. · Neurology Neuroimmunology & Neuroinflammation · 2016 · 152 citations · Full text

Medicine, Neurology, Immunopathology +14